Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

NCT06234748 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Oropharynx Cancer
HPV-Related Carcinoma

Interventions

RADIATION: Radiation
DRUG: Platinum based chemotherapy

Sponsor

University of Michigan Rogel Cancer Center